These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 11861807

  • 1. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
    Di Marzo V, Griffin G, De Petrocellis L, Brandi I, Bisogno T, Williams W, Grier MC, Kulasegram S, Mahadevan A, Razdan RK, Martin BR.
    J Pharmacol Exp Ther; 2002 Mar; 300(3):984-91. PubMed ID: 11861807
    [Abstract] [Full Text] [Related]

  • 2. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):275-84. PubMed ID: 10448105
    [Abstract] [Full Text] [Related]

  • 3. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ.
    Eur J Pharmacol; 2001 May 25; 420(2-3):123-31. PubMed ID: 11408034
    [Abstract] [Full Text] [Related]

  • 4. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR.
    Biochem Biophys Res Commun; 2001 Feb 23; 281(2):444-51. PubMed ID: 11181068
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
    Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JF, Bär PR, Nicolay K, Di Marzo V.
    J Neurosci; 2003 May 15; 23(10):4127-33. PubMed ID: 12764100
    [Abstract] [Full Text] [Related]

  • 6. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.
    Di Marzo V, Breivogel C, Bisogno T, Melck D, Patrick G, Tao Q, Szallasi A, Razdan RK, Martin BR.
    Eur J Pharmacol; 2000 Oct 20; 406(3):363-74. PubMed ID: 11040343
    [Abstract] [Full Text] [Related]

  • 7. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG.
    Br J Pharmacol; 2001 Feb 20; 132(3):631-40. PubMed ID: 11159715
    [Abstract] [Full Text] [Related]

  • 8. Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.
    Brooks JW, Pryce G, Bisogno T, Jaggar SI, Hankey DJ, Brown P, Bridges D, Ledent C, Bifulco M, Rice AS, Di Marzo V, Baker D.
    Eur J Pharmacol; 2002 Mar 29; 439(1-3):83-92. PubMed ID: 11937096
    [Abstract] [Full Text] [Related]

  • 9. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V.
    FEBS Lett; 2000 Oct 13; 483(1):52-6. PubMed ID: 11033355
    [Abstract] [Full Text] [Related]

  • 10. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V.
    Br J Pharmacol; 2001 Oct 13; 134(4):845-52. PubMed ID: 11606325
    [Abstract] [Full Text] [Related]

  • 11. Recent advances in the synthesis of endocannabinoid related ligands.
    Razdan RK, Mahadevan A.
    Chem Phys Lipids; 2002 Dec 31; 121(1-2):21-33. PubMed ID: 12505687
    [Abstract] [Full Text] [Related]

  • 12. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V.
    Biochem Pharmacol; 2003 May 01; 65(9):1473-81. PubMed ID: 12732359
    [Abstract] [Full Text] [Related]

  • 13. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
    Sharkey KA, Cristino L, Oland LD, Van Sickle MD, Starowicz K, Pittman QJ, Guglielmotti V, Davison JS, Di Marzo V.
    Eur J Neurosci; 2007 May 01; 25(9):2773-82. PubMed ID: 17459108
    [Abstract] [Full Text] [Related]

  • 14. New perspectives on enigmatic vanilloid receptors.
    Szallasi A, Di Marzo V.
    Trends Neurosci; 2000 Oct 01; 23(10):491-7. PubMed ID: 11006466
    [Abstract] [Full Text] [Related]

  • 15. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response.
    Hermann H, De Petrocellis L, Bisogno T, Schiano Moriello A, Lutz B, Di Marzo V.
    Cell Mol Life Sci; 2003 Mar 01; 60(3):607-16. PubMed ID: 12737320
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
    Lichtman AH, Hawkins EG, Griffin G, Cravatt BF.
    J Pharmacol Exp Ther; 2002 Jul 01; 302(1):73-9. PubMed ID: 12065702
    [Abstract] [Full Text] [Related]

  • 17. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
    Jerman JC, Gray J, Brough SJ, Ooi L, Owen D, Davis JB, Smart D.
    Br J Anaesth; 2002 Dec 01; 89(6):882-7. PubMed ID: 12453933
    [Abstract] [Full Text] [Related]

  • 18. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism.
    De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V.
    J Biol Chem; 2001 Apr 20; 276(16):12856-63. PubMed ID: 11278420
    [Abstract] [Full Text] [Related]

  • 19. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S, Khanolkar AD, Fan P, Goutopoulos A, Qin C, Papahadjis D, Makriyannis A.
    J Med Chem; 1998 Dec 31; 41(27):5353-61. PubMed ID: 9876105
    [Abstract] [Full Text] [Related]

  • 20. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M.
    Brain Res Mol Brain Res; 2004 Dec 06; 132(1):87-92. PubMed ID: 15548432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.